MedTrace Logo

Study of a Novel Non-invasive Glucose Monitoring Device

NCT03782441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-12-03

No results posted yet for this study

Summary

This explorative clinical study has been launched to collect spectral Raman data paired with validated glucose reference values in diabetic patients.

Conditions

Interventions

DEVICE

Prototype 0.5

Investigational Medical Device collecting spectral Raman data from tissue

Sponsors & Collaborators

  • RSP Systems A/S

    lead INDUSTRY

Principal Investigators

  • Sanne Fisker · Steno Diabetes Center, Aarhus University Hospital

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-05
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03782441 on ClinicalTrials.gov